Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  212.79
+3.02 (1.44%)
AAPL  258.86
+2.94 (1.15%)
AMD  220.18
+2.68 (1.23%)
BAC  50.06
+0.68 (1.38%)
GOOG  297.66
+3.20 (1.09%)
META  573.02
-1.44 (-0.25%)
MSFT  372.88
-0.58 (-0.16%)
NVDA  177.64
+0.25 (0.14%)
ORCL  145.54
-0.84 (-0.57%)
TSLA  352.82
-7.77 (-2.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.